Raj Kannan - Mar 18, 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Signature
/s/ John LaRocca, Attorney-In-Fact for Raj Kannan
Stock symbol
AERI
Transactions as of
Mar 18, 2022
Transactions value $
$0
Form type
4
Date filed
3/22/2022, 08:26 PM
Previous filing
Dec 22, 2021
Next filing
Nov 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AERI Stock Option (right to buy) Award $0 +197K $0.00 197K Mar 18, 2022 Common Stock 197K $8.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on March 18, 2023 and as to the remaining underlying shares in substantially equal installments on each of the subsequent 36 monthly anniversaries of March 18, 2023.